Hongxiao Li Selected Research

Hematoxylin (Haematoxylon)

2/2023	Moxibustion mitigates mitochondrial dysfunction and NLRP3 inflammatory activation in cyclophosphamide-induced premature ovarian insufficiency rats.
1/2023	Isolation of Swine Bone Marrow Lin-/CD45-/CD133 + Cells and Cardio-protective Effects of its Exosomes.
1/2022	Deep Learning-Based Pathology Image Analysis Enhances Magee Feature Correlation With Oncotype DX Breast Recurrence Score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongxiao Li Research Topics

Disease

6	Neoplasms (Cancer) 11/2022 - 01/2019
4	Triple Negative Breast Neoplasms 12/2023 - 09/2021
3	Inflammation (Inflammations) 02/2024 - 04/2022
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Ulcerative Colitis 04/2024 - 01/2023
2	Wounds and Injuries (Trauma) 02/2024 - 04/2022
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2019
1	Infections 02/2024
1	Oligospermia (Oligozoospermia) 01/2024
1	Dehydration (Water Stress) 10/2023
1	Weight Loss (Weight Reduction) 10/2023
1	Weight Gain 10/2023
1	Hemorrhage 10/2023
1	Hypotension (Low Blood Pressure) 10/2023
1	Lung Neoplasms (Lung Cancer) 10/2023
1	Obstructive Sleep Apnea 06/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2023
1	Gastroenteritis 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Diabetic Foot 04/2022
1	Ulcer 04/2022
1	Necrosis 01/2022
1	Polyploidy 01/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022
1	Lung Diseases (Lung Disease) 01/2021
1	ST Elevation Myocardial Infarction 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Myocardial Infarction 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Leukopenia 01/2019
1	Adenocarcinoma 01/2019
1	Adenocarcinoma of Lung 01/2019

Drug/Important Bio-Agent (IBA)

3	Eosine Yellowish-(YS) (Eosin)IBA 02/2023 - 01/2022
3	Hematoxylin (Haematoxylon)IBA 02/2023 - 01/2022
2	phytobacteriomycin (PBM)IBA 02/2024 - 04/2022
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2023 - 01/2022
2	ophiopogonin BIBA 01/2021 - 01/2019
1	Interleukin-6 (Interleukin 6)IBA 02/2024
1	GlycosidesIBA 01/2024
1	SodiumIBA 10/2023
1	isopreneIBA 10/2023
1	Volatile Organic CompoundsIBA 10/2023
1	AcetoneIBA 10/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	C-Reactive ProteinIBA 06/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2023
1	EnzymesIBA 02/2023
1	ImmunosorbentsIBA 02/2023
1	Angiotensin IIIBA 01/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 11/2022
1	histone H3 trimethyl Lys4IBA 08/2022
1	Histones (Histone)IBA 08/2022
1	Lysine (L-Lysine)FDA Link 08/2022
1	CollagenIBA 04/2022
1	Estrogen ReceptorsIBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	CateninsIBA 01/2021
1	SaponinsIBA 01/2021
1	Troponin IIBA 01/2020
1	Sodium Chloride FDA LinkGeneric 01/2020
1	lauroyl-alpha-hydroxyethyl sulfonic acidIBA 04/2019
1	PlatinumIBA 01/2019

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
3	Therapeutics 04/2024 - 04/2022
3	Neoadjuvant Therapy 12/2023 - 01/2022
2	Moxibustion 01/2024 - 02/2023
1	Low-Level Light Therapy (LLLT) 02/2024
1	MBD protocol 02/2024
1	Duration of Therapy 10/2023
1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Percutaneous Coronary Intervention 01/2020